| 2017 |
Van Sebille,Y, Gibson,R, Wardill,H, Secombe,K, Ball,I, Keefe,D, Finnie,J, Bowen,J, 2017, Dacomitinib-induced diarrhoea is associated with altered gastrointestinal permeability and disruption in ileal histology in rats, International Journal of Cancer, 140, 12, 2820-2829 10.1002/ijc.30699 |
| 2017 |
Coller,J, Bowen,J, Ball,I, Wardill,H, van Sebille,Y, Stansborough,R, Lightwala,Z, Wignall,A, Shirren,J, Secombe,K et al, 2017, Potential safety concerns of TLR4 antagonism with irinotecan: a preclinical observational report, Cancer Chemotherapy and Pharmacology, 79, 2, 431-434 10.1007/s00280-016-3223-3 |
| 2016 |
Wardill,H, Gibson,R, Van Sebille,Y, Secombe,K, Coller,J, White,I, Manavis,J, Hutchinson,M, Staikopoulos,V, Logan,R et al, 2016, Irinotecan-induced gastrointestinal dysfunction and pain are mediated by common TLR4-dependent mechanisms, Molecular Cancer Therapeutics, 15, 6, 1376-1386 10.1158/1535-7163.MCT-15-0990 |
| 2016 |
Wardill,H, Gibson,R, Van Sebille,Y, Secombe,K, Logan,R, Bowen,J, 2016, A novel in vitro platform for the study of SN38-induced mucosal damage and the development of Toll-like receptor 4-targeted therapeutic options, Experimental Biology and Medicine, 241, 13, 1386-1394 10.1177/1535370216640932 |
| 2016 |
Wardill,H, Bowen,J, Van Sebille,Y, Secombe,K, Coller,J, Ball,I, Logan,R, Gibson,R, 2016, TLR4-dependent claudin-1 internalization and secretagogue-mediated chloride secretion regulate irinotecan-induced diarrhea, Molecular Cancer Therapeutics, 15, 11, 2767-2779 10.1158/1535-7163.MCT-16-0330 |
